Keyphrases
CD19
100%
Bispecific
100%
Leukemia-lymphoma
100%
CD22
100%
Mouse Xenograft Model
100%
B-cell Leukemia
100%
Recombinant Immunotoxin
100%
Anti-CD19
50%
Daudi
50%
CD19/CD22
50%
Immunotoxin
33%
Escherichia Coli
16%
Tumor Growth
16%
Sodium
16%
Monoclonal Antibody
16%
New Drugs
16%
Fusion Protein
16%
Leukemia Cells
16%
CD19+
16%
B-cell Malignancies
16%
Human muscle
16%
Tumor Therapy
16%
Anticancer Activity
16%
IC50
16%
Catalytic Domain
16%
Detergent
16%
Diphtheria Toxin
16%
Prolonged Survival
16%
Chain Molecules
16%
Therapy Models
16%
Systemic Model
16%
DT390
16%
Raji Cells
16%
Severe Combined Immunodeficient Mice
16%
Aldolase
16%
Sodium Lauroyl Sarcosinate
16%
Translocation Domain
16%
Pharmacology, Toxicology and Pharmaceutical Science
Receptor
100%
Immunotoxin
100%
B Cell Leukemia
100%
Leukemia
66%
Diphtheria Toxin
33%
SCID Mouse
33%
Escherichia coli
33%
Tumor Growth
33%
Chimeric Protein
33%
Fructose Bisphosphate Aldolase
33%
IC50
33%
Neoplasm
33%
Monoclonal Antibody
33%
Sarcosine
33%
Immunology and Microbiology
Xenograft
100%
B Cell
100%
CD19
100%
Immunotoxin
100%
CD22
100%
Monoclonal Antibody
16%
Antineoplastic Activity
16%
Escherichia coli
16%
Leukemia Cell
16%
IC50
16%
SCID Mouse
16%
Flank
16%
Muscle
16%